New stroke breakthroughs spotlight faster treatment, factor XI prevention, better recovery, and the push to deliver care equitably with smart wearables.
Ashkan Shoamanesh, MD, FRCPC
Advertisement
Associate professor, Division of Neurology
McMaster University in Hamilton, Canada
Articles by Ashkan Shoamanesh, MD, FRCPC
Ashkan Shoamanesh, MD, discusses a secondary analysis of the efficacy and safety of the factor XIa inhibitor asundexian by underlying stroke etiology.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Lipoprotein(a): An FAQ on Awareness, Risk, and Screening Gaps
2
$20 Billion National Strategy Aims to Close the Women's Health Gap
3
Smartwatch Study Links Midlife to Rising Nighttime Awakenings in Women
4
5 Novel FDA Approvals That Signal a Shift Toward Convenience-Driven Care
5